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ABSTRACT 
The endogenous lipid agent N-arachidonoylethanolamine (anandamide), among other 
effects, has been shown to be involved in nociceptive processing both in the central 
and peripheral nervous systems. Anandamide is thought to be synthesised by several 
enzymatic pathways both in a Ca2+-sensitive and Ca2+-insensitive manner, and rat 
primary sensory neurons produce anandamide. Here, we show for the first time, that 
cultured rat primary sensory neurons express at least four of the five known Ca2+-
insensitive enzymes implicated in the synthesis of anandamide, and that application of 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-arachidonoyl, the common 
substrate of the anandamide-synthesising pathways, results in anandamide production 
which is not changed by the removal of extracellular Ca2+. We also show that 
anandamide, which has been synthesised in primary sensory neurons following the 
application of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-arachidonoyl 
induces transient receptor potential vanilloid type 1 ion channel-mediated excitatory 
effect that is not inhibited by concomitant activation of the cannabinoid type 1 
receptor. Finally, we show that sub-populations of transient receptor potential 
vanilloid type 1 ion channel-expressing primary sensory neurons also express some of 
the putative Ca2+-insensitive anandamide-synthesising enzymes. Together, these 
findings indicate that anandamide synthesised by primary sensory neuron via a Ca2+-
insensitive manner has an excitatory rather than an inhibitory role in primary sensory 
neurons and that excitation is mediated predominantly through autocrine signalling. 
Regulation of the activity of the Ca2+-insensitive anandamide-synthesising enzymes in 
these neurons may be capable of regulating the activity of these cells, with potential 
relevance to controlling nociceptive processing in these neurons. 
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INTRODUCTION 
N-arachidonoylethanolamine (anandamide) [7] is an endogenous lipid agent 
implicated in a variety of physiological functions and pathological processes both 
within, and outside, the nervous system [3, 21]. Although anandamide interacts with a 
variety of proteins [15], the majority of its actions are mediated via the cannabinoid 
type 1 (CB1) receptor and the transient receptor potential vanilloid type 1 ion channel 
(TRPV1) [6, 7, 9, 26, 51]. One of the most prominent functions of anandamide resides 
in its TRPV1- and CB1 receptor-mediated regulatory action in nociception in primary 
sensory neurons (PSN) [9].  
Several cell types in various tissues, including PSN, produce anandamide [5, 
8, 10, 44, 45,], the synthesis of which is believed to occur either in a Ca2+-sensitive, or 
Ca2+-insensitive manner [22, 23, 32, 36, 41, 43, 47, 48] and through several 
enzymatic pathways (Figure 1). The molecular identities and biochemical activities of 
six enzymes implicated in the synthesis of various N-acylethanolamines (NAEA) 
including anandamide from corresponding N-acylphosphatidyl-ethanolamines 
(NAPE) have now been established (Figure 1) [22, 23, 32, 36, 41, 43]. We have 
recently shown that one of these six enzymes, N-acylphosphatidylethanolamine-
selective phospholipase D (NAPE-PLD, Figure 1), which is the only known Ca2+-
sensitive enzyme involved in anandamide synthesis [32, 43, 47, 48], is expressed by a 
sub-population of PSN [29]. However, the ability of PSN to produce anandamide in 
the absence of Ca2+ [45] indicates that, in addition to the Ca2+-sensitive pathway 
(Figure 1), one, or more, Ca2+-insensitive pathways must also be present in these 
cells.  
Anandamide synthesised in a Ca2+-sensitive manner induces excitation of PSN 
through the activation of TRPV1 [44]. However, the effect of anandamide synthesised 
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by Ca2+-insensitive enzymes acting on NAPE in PSN is not known. Therefore, after 
having first examined the expression and function of putative Ca2+-insensitive NAPE-
converting enzymes, we also studied the effect of anandamide produced by these 
enzymes, in cultured rat PSN.  
 
MATERIALS AND METHODS 
All experiments were performed in accordance with the UK Animals 
(Scientific Procedures) Act 1986, and the Directive 2010/63/EU of the European 
Parliament and of the Council on the Protection of Animals Used for Scientific 
Purposes. Every effort was taken to minimize the number of animals used. Altogether 
seventy eight 80-120 g male Sprague-Dawley rats, five wild type (C57BL/6 x129SvJ; 
WT) and six TRPV1-/- mice (with C57BL/6 x129SvJ background; KO) were used. 
 
Drugs  
The following compounds were used: 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-arachidonoyl (20:4-NAPE; Avanti Polar, dissolved in 1:1 
ethanol:Tocrisolve (Tocris)); capsaicin (Tocris, dissolved in dimethyl sulphoxide 
(DMSO, Sigma)); capsazepine (Tocris, dissolved in DMSO); (5Z,8Z,11Z,14Z)-
5,8,11,14-eicosatetraenyl-methyl ester phosphonofluoridic acid (MAFP; Tocris, 
dissolved in DMSO); rimonabant (Cayman Chemicals, dissolved in DMSO), mustard 
oil (Sigma, dissolved in DMSO).  
 
Chloroform, in which 20:4-NAPE is delivered, was evaporated in a N2 
atmosphere. Dried 20:4-NAPE was stored at -80 °C and re-dissolved in ethanol (100 
mM) on the day of the experiment and stored at -20 °C for a maximum of a month. 
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The final stock solution (50mM) of 20:4-NAPE was prepared by adding equal volume 
of tocrisolve to the 100 mM 20:4 NAPE and vortexed. This final stock was used on 
the day of the preparation. The maximum final concentration of Tocrisolve and 
ethanol were 0.05%. The maximum final concentration of DMSO was also 0.05%. 
 
Cultures of dorsal root ganglia  
Dorsal root ganglion (DRG) cultures were prepared as described [31]. Briefly, 
DRG from the first cervical to the sixth lumbar segment were collected in Ham's 
nutrient F12 culture medium (Sigma) supplemented with 2% Ultroser G (BioSepra 
SA), 1 mM glutamine (Invitrogen), 50 IU/ml penicillin (Invitrogen) and 50 µg/ml 
streptomycin (Invitrogen). Following incubation in 2000 U/ml collagenase type IV 
(Worthington Biochemical Corporation) for 3 hours, DRG were triturated and the 
cells were plated on poly-DL-ornithine (Sigma)-coated glass coverslips. Cells were 
grown for 24-48 hours in the supplemented medium to which nerve growth factor 
(NGF, 50 ng/ml; Promega), was added. For Ca2+-imaging experiments, after 
trituration, the cell suspension was centrifuged through 15% bovine serum albumin 
(Sigma) and then also supplemented with 10 µM cytosine arabinoside (Sigma). 
 
Isolation of total RNA  
The total RNA was isolated using QIA shredder and RNeasy Mini or RNeasy 
Plus Mini Kits (Qiagen), as described [31].  
 
Reverse transcriptase polymerase chain reaction (RT-PCR)  
Extracted RNA (1 µg) was reverse-transcribed using SuperScript II cDNA 
synthesis reagents (Invitrogen). Primers designed to amplify rat 
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glycerophosphodiester phosphodiesterase 1 (GDE1, NM_198779.1), α/β-hydrolase 4 
(ABHd4, NM_001108866.1), protein tyrosine phosphatase, non-receptor type 22 
(PTPn22, NM_001106460.1), group 1b secretory phospholipase A2 (sPLA2G1b, 
NM_031585.1), inositol 5’ phosphatase (Inpp5, NM_019311.1) and the housekeeping 
gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH, NC_005103) were 
perchased from Eurofins. The sequences of the primers, annealing temperatures and 
the predicted product sizes are shown in Table 1.  
The PCR reaction mixture contained cDNA, forward and reverse primers, 1.5 
mM MgCl2, 1× Green Go-Taq Reaction buffer (Promega), 0.2 mM deoxynucleotide 
mix (Promega) and 1.25 U Go-Taq DNA polymerase (Promega). The amplification 
reaction consisted of 30 cycles with 0.5 minutes of denaturation at 95 °C, 1 min 
annealing at the given temperatures (Table 1), and followed by 1 minute final 
extension at 72 °C in a thermal cycler (Eppendorf-Mastercycler Personal, Eppendorf). 
For GAPDH, the amplification reaction consisted of only 25 cycles. PCR products 
were separated on 2% agarose gels by electrophoresis and visualized with ethidium 
bromide. 
 
Immunofluorescence staining  
Cells attached to the coverslips were washed with PBS and fixed by 4% 
paraformaldehyde in 0.1 M PBS (pH 7.4). Permeabilisation (0.3% Triton-X 100), and 
blocking (10% normal donkey serum) were followed by overnight incubation at 4 ºC 
with primary antibodies at dilutions listed in Table 2, and visualisation with secondary 
antibodies. Coverslips were mounted on glass slides with Vectashield containing 
DAPI (Vector Laboratories) and examined using a Leica DMR Fluorescence 
microscope. Images were captured on a Hamamatsu CCD camera using the QWin 
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software package (Leica). On some images the brightness and contrast were digitally 
modified. For control, the primary antisera were omitted, or the immunoreactions 
were performed on sections of tissues in which the expression of the various 
anandamide-synthesising enzymes had been shown previously. While no staining in 
PSN neurons was seen when the primary antibodies were omitted, enzyme expression 
was seen in various tissues with already demonstrated expression of the anandamide-
synthesising enzymes (data not shown).     
 
Anandamide release  
Cultures were washed twice with HBSS-HEPES buffer (in mM: NaCl 111, 
KCl 3, MgCl2 0.49, CaCl2 1.27, glucose 5.5, MgSO4 0.4, KH2PO4 0.44, Na2HPO4 
0.33, HEPES 10, 100 nM MAFP, pH 7.4) then incubated for 5 minutes in HBSS-
HEPES buffer or HBSS-HEPES buffer containing 20:4-NAPE (30 nM, 100 nM, 300 
nM, 1 µM, 3 µM, 10 µM, 30 µM, 100 µM). In some experiments CaCl2, was omitted 
from, and 10 mM ethylene glycol tetraacetic acid (EGTA, Sigma) was added to the 
buffer. All the washes and incubations were carried out at 37 ºC unless stated 
otherwise.  
The superfusate was collected on ice and either processed immediately for 
lipid extraction or stored at -80 ºC for further processing. Cells were immediately 
scraped into ice-cold cell-lysis buffer, used for protein quantification using BCA 
Protein Assay Reagent. For some anandamide measurements, only 10% of the cells 
were used for protein quantification. The remaining 90% of the cells were stored in 
methanol, and then added to the buffer for anandamide measurements.  
 
Anandamide measurements  
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The 20:4-NAPE application-induced anandamide synthesis was measured 
using three slightly different methods (Supplementary Figure 1). For protocol A 
(Supplementary Figure 1A), lipids were extracted from the buffer into ethyl acetate. 
Following evaporation of ethyl acetate, lipids were reconstituted in acetonitrile prior 
to quantification of anandamide by ultra-high performance liquid chromatography-
electrospray-tandem mass spectrometry (UHPLC-ESI-MS/MS) using an Acquity 
UPLC BEH C18 (2.1 x 30 mm) column (Waters) with an Acquity UPLC BEH C18 
VanGuard Pre column (Waters) maintained at 60 °C and a Shimadzu Nexera UHPLC 
(Shimadzu Scientific Instruments). Mobile phases comprised A (water containing 
0.1% formic acid) and B (acetonitrile containing 0.1% formic acid) and the gradient 
conditions were: 0 minute, 2% B; 1.8 minutes, 95% B; 2.3 minutes, 95% B, 2.31 
minutes, 2% B then re-equilibrated at 2% B until 3.0 minutes. Samples were 
maintained at 4 °C throughout. Analytes were detected using tandem electrospray 
mass spectrometry in positive ion mode (API 4000, ABSciex) and multiple reaction 
monitoring with transitions of m/z 348.5>62.0 and m/z 348.5>91.052 for anandamide 
and m/z 260.420>116.200 for propranolol, used as internal standard (Supplementary 
Figure 1A). Anandamide concentrations were derived from the relative response 
against authentic standards using Analyst 1.5.1 (ABSciex). The threshold of 
quantitation was 0.01 nM. 
For protocol B (Supplementary Figure 1B), lipids were extracted from the 
superfusate using solid-phase extraction as described [19]. Briefly, superfusates, 
buffers and cell-free controls were supplemented with octa-deuterated anandamide 
(Cayman Chemicals, 2.5 pmol/ml) and loaded onto a pre-conditioned Oasis HLB 1 
cc, 30 mg cartridge (Waters). Cartridges were washed with 40% aqueous methanol 
and then eluted with acetonitrile (1 ml, Fisher Scientific). Eluants were dried under 
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constant N2 stream and then re-suspended in acetonitrile (80 µl). Quantification of 
anandamide was done by UHPLC-ESI-MS/MS as described [25] using an Acquity 
UPLC BEH C18 (2.1 x 50 mm) column (Waters) maintained at 40 °C and an Acquity 
UHPLC system (Waters). Mobile phases comprised A (2 mM ammonium acetate 
containing 0.1% formic acid and 5% acetonitrile) and B (acetonitrile containing 0.1% 
formic acid) and the gradient conditions were: 0-0.5 minutes, 20% B; 2.5 minutes, 
100% B; 3.5 minutes, 20% B then re-equilibrated at 20% B until 4.0 minutes. 
Samples were maintained at 4 °C throughout. Analytes were detected using tandem 
ESI-MS/MS in positive ion mode (Quattro Premier tandem mass spectrometer, 
Waters) and multiple reaction monitoring with transitions of m/z 348.25>61.85 and 
m/z 356.4>63.0 for anandamide and deuterated anandamide internal standard, 
respectively (Supplementary Figure 1B). Anandamide concentrations were derived 
from the relative response against authentic standards using Quanlynx (Waters). The 
threshold of quantitation was 0.005 nM. 
Protocol C (Supplementary Figure 1C) was used in experiments in which the 
anandamide content of the superfusate and cells were measured together. Here, the 
samples were treated with 5 pmol octa-deuterated anandamide (Cayman Chemicals) 
in 1 volume of chloroform/methanol (2:1 by vol.) and sonicated for 1 minute in a 
sonication bath. The aqueous phase was then extracted twice with chloroform (1 
volume). The three, pooled organic phases were lyophilized and purified on silica 
mini columns as previously described [25]. The silica column fractions containing 
anandamide were analysed by liquid chromatography-atmospheric pressure-mass 
spectrometry (LC-APCI-MS) conducted as described [25]. Analyses were carried out 
in the selected ion-monitoring mode using m/z values of 356 and 348 (molecular ions 
+1 for deuterated and undeuterated anandamide), using a Shimadzu HPLC apparatus 
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(LC-10ADVP; Shimadzu Scientific Instruments) coupled to a Shimadzu (LCMS-
2020) quadrupole MS via a Shimadzu APCI interface (Shimadzu Scientific 
Instruments; Supplementary Figure 1C). The threshold of quantitation was 0.005 nM. 
 
Cobalt uptake  
Cobalt uptake was assessed as described [24, 34, 38, 39]. Briefly, cells 
attached to the coverslips were washed in a buffer containing (in mM): NaCl 57.5, 
KCl 5, MgCl2 2, HEPES 10, glucose 12, sucrose 139 (pH 7.4) then incubated in the 
presence cobalt (5 mM) put into the buffer with or without 20:4-NAPE (100 nM, 1 
µM, 10 µM, 100 µM,) for 5 minutes at 37 ºC. The cobalt taken up by the cells was 
precipitated by 2.5% β-mercaptoethanol (Sigma). Cells were then fixed in 70% 
ethanol and the coverslips were mounted on glass slides with glycerol. The mean gray 
value of more than 100 cells which were chosen randomly but systemically was 
established by a Leica light microscope attached to a PC running the QWin software 
package (Leica), and analysed with the ImageJ software package (NIH, USA) as 
described [24, 34, 38, 39]. 
 
Whole-cell voltage-clamp recordings  
An Axopatch 200B amplifier and a Digidata 1200 digitizer (Molecular 
Devices, UK) were used to record whole-cell currents from cultured PSN as described 
[31]. Borosilicate glass micropipettes (4-6 MΩ) were pulled on a DMZ puller (DMZ), 
and filled with the following solution (concentrations in mM): NaCl 5, KCl 150, 
MgCl2 2, HEPES 10, EGTA 1; pH 7.4. The extracellular buffer contained (in mM): 
NaCl 150, KCl 5, MgCl2 2, CaCl2 2, HEPES 10, glucose 10; pH 7.4. All recordings 
were done at 37 ºC and collected with the pClamp 8 software package (Molecular 
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Devices) with 1 kHz sampling rate and 5 kHz filtering. The holding potential was -60 
mV. Recordings were analysed off-line by the ClampFit 8.0 software package 
(Molecular Devices).  
 
Ca2+ imaging  
Cells were loaded with Fura-2 acetoxymethyl ester (Fura-2 AM, 5 µM; 
Molecular Probes) in the presence of 2 mM probenecid (Molecular Probes) for 60 
minutes at 37 ºC in a HEPES-buffered saline (in mM): NaCl, 122; KCl, 3.3; CaCl2, 
1.3; MgSO4, 0.4; KH2PO4 1.2; HEPES, 25; glucose, 10; adjusted with NaOH to pH 
7.3. Coverslips were superfused with extracellular solution (in mM: NaCl, 160; KCl, 
2.5; CaCl2, 1; MgCl2, 2; HEPES, 10; glucose, 10; pH 7.3) in a laminar flow perfusion 
chamber (Warner Instrument Corporation). The following test solutions were applied 
subsequently: 20:4-NAPE (50 µM), capsaicin (1 µM) and KCl (50 mM) (timing is 
indicated in the corresponding Figures). For studying the involvement of TRPV1 or 
the CB1 receptor in the 20:4-NAPE-evoked responses, either capsazepine (5 µM), or 
rimonabant (200 nM) was used to inhibit TRPV1 or the CB1 receptor, respectively. 
The antagonists were applied for 60 seconds prior the application of 20:4-NAPE 
together with capsazepine or rimonabant. For control purposes, following the 
application of 20:4-NAPE together with capsazepine or rimonabant, the antagonists 
were not removed from the bath and capsaicin with capsazepine or rimonabant was 
applied. Only KCl-sensitive cells (neurons) were involved in subsequent analyses. At 
the end of some experiments, mustard oil (50 µM; Sigma) or/and ionomycin (5 µM, 
Sigma) was also applied. Application of drugs was controlled manually with one 
visual field being tested per coverslip. Experiments were performed at 37 ºC, except 
where otherwise indicated. 
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Images were captured with a Peltier element-cooled slow scan charge-coupled 
camera system (PTI). Following subtraction of the background fluorescence, the ratio 
of fluorescence intensity at the two wavelengths as a function of time (rate 1 Hz) was 
automatically calculated (R = F340/F380) and the resultant graphs analysed using the 
ImageMaster 5.0 sofware package (PTI) and the Microsoft Excel software package. 
Only recordings with a stable baseline before 20:4-NAPE application, were included 
in the analyses. First, the noise and baseline before the first drug application were 
established. Then, the maximum amplitude of the 340/380 ratio was established in 
defined sections of recordings. Each of these defined sections started at the beginning 
of a drug application and lasted until the beginning of the next drug application. An 
increase of more than 10% in the 340/380 ratio was then regarded as a response, if, 
during visual verification, the change was clearly associated with the drug application. 
Based on our pilot data, 2.5 times of the standard deviation of the amplitude of the 
baseline noise equals with a maximum of 9.5-10% increase in the 340/380 ratio. 
 
Statistics  
Data of repeated measurements were averaged. Differences between the 
averaged values were analysed by Student’s t-test, one-way analysis of variance 
(ANOVA) or repeated measure multivariate ANOVA as appropriate. In ANOVA, 
following checking the normality of data, post hoc analysis for the statistically 
significant differences among the treatment groups was performed by the Fischer`s 
test. Significant differences in the proportion of neurons responding to various drugs 
were assessed by Fisher’s exact test. Data are shown as mean ± standard error of 
mean. A difference between two values was considered to be significant if p<0.05. 
The n values refer to the number of repeated experiments (number of cultures used for 
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immunohistochemistry, anandamide release measurements and cobalt uptake, and the 
number of cells measured in whole-cell recordings and calcium imaging) and p values 
are given as <0.0001 if the actual value was smaller than that.  
 
 
RESULTS 
Several Ca2+-insensitive enzymes, which are implicated in anandamide synthesis, 
are expressed in rat cultured primary sensory neurons  
RT-PCR analysis showed gene expression for all five Ca2+-insensitive 
enzymes that are known to be implicated in the synthesis of NAEA, including 
anandamide, from the corresponding NAPEs in cultures prepared from rat DRG 
(Figure 1 and Figure 2A). In order to study the expression of the enzymes at a cellular 
level, immunostaining was performed on cultured rat PSN using antibodies raised 
against the enzymes together with an anti-NeuN-antibody, which identifies neurons. 
By analysing the staining in at least 100 neurons in each culture, we found that sub-
populations of PSN express ABHd4, GDE1, Inpp5, and PTPn22 (Figure 2B; for the 
proportions of cells expressing these enzymes please see Table 3). The analysis also 
revealed that while only neurons express ABHd4, Inpp5 and PTPn22, neurons and 
some non-neuronal cells express GDE1 (Figure 2B).  
The antibody raised against sPLA2G1b did not produce staining in the 
cultures. However, the same antibody produced staining in the pancreas (data not 
shown). The anti-ABHd4-, anti-Inpp5-, anti- PTPn22- and anti-GDE1 antibodies also 
produced staining in tissues in which the expression of these enzymes have been 
reported previously (data not shown). When the primary antibodies were replaced 
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with normal serum, no staining was seen either in cultured PSN or in any tissues 
which we processed (data not shown). 
  
Application of 20:4-NAPE induces anandamide production in cultured PSN  
20:4-NAPE is the substrate for anandamide synthesis used by all the known 
enzymatic pathways (Figure 1) [20, 22, 23, 32, 36, 37, 41, 43]. Therefore, to ascertain 
whether the enzymes found to be expressed in cultured rat PSN form any functional 
anandamide-synthesising pathways, the level of 20:4-NAPE application-induced 
anandamide synthesis was measured. 
Exposure of the cells to 100 µM 20:4-NAPE significantly increased the 
anandamide content of the buffer from a level below the quantitation threshold in the 
control to 8.86±3.44 pmol/ml (n=4; Student’s t-test, p=0.01; Protocol B) at 37 °C. 
After normalisation to the protein content, the anandamide concentration was 
13.25±4.39 ng/mg protein (n=4; Figure 3A). Incubation of the cells in the vehicle 
resulted in an anandamide content of 0.01±0.01 ng/mg (n=3) protein in the 
superfusate (data not shown). This value was not significantly different from that 
measured in the control of this experiment (0.04±0.04 ng/mg protein, n=3; p=0.5, 
Student’s t-test). Incubation of the cells in 100 µM 20:4-NAPE at room temperature 
also significantly increased the anandamide concentration in the buffer (from 
0.06±0.03 ng/mg protein to 1.17±0.03 ng/mg protein, n=3; Student’s t-test, p=0.009; 
Figure 3B). However, the 20:4-NAPE application-induced increase in the anandamide 
content of the buffer at room temperature was significantly less than that measured at 
37 °C (Student’s t-test, p=0.03) indicating that the production of anandamide depends 
on enzyme activity. To make sure that no 20:4-NAPE hydrolysing activity in the 
buffer contributed to the increase in the anandamide levels, we also quantified the 
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anandamide content of cell-free superfusate containing 100 µM 20:4-NAPE. The 
buffer was kept either at room temperature or 37 ºC up to 4 hours. We measured the 
lowest and highest anandamide concentration at 2.5 hours at 37 ºC (0.023 ng/ml) and 
at 5 minutes at 37 ºC (0.15 ng/ml), respectively. We found no apparent relationship 
between the anandamide content and the time or temperature of incubation (Data not 
shown). These data indicated that cultured rat PSN has the ability to convert 20:4-
NAPE into anandamide.  
The 20:4-NAPE application-evoked increase in the anandamide content of the 
supernatant at 37 °C was concentration-dependent (Figure 3C; Protocol A). The 
lowest 20:4-NAPE concentration at which the anandamide content of the superfusate 
was significantly different from that of the control was 10 µM (ANOVA followed by 
Fisher’s test, p=0.03). 
Among the known anandamide-synthesising enzymes, NAPE-PLD activity is 
significantly enhanced in the presence of Ca2+ [32, 42, 43, 47, 48]. To ascertain 
whether or not during 20:4-NAPE application, any Ca2+ influx increases the 
intracellular Ca2+ concentration [Ca2+]i to an extent which is enough to contribute  
NAPE-PLD to anandamide synthesis, we applied 20:4-NAPE to cultured PSN either 
with Ca2+ present or absent in the buffer. In the presence of Ca2+, the anandamide 
content of the superfusate of cells incubated with vehicle was 0.62±0.35 ng/mg 
protein (n=3), whereas in the absence of Ca2+, it was 0.98±0.12 ng/mg protein (n=3; 
Protocol A). These values did not differ significantly from each other (Student’s t-
test, p=0.4; Figure 3D). Application of 20:4-NAPE (100 µM) resulted in a significant 
increase in the anandamide content of the superfusate in both the presence and 
absence of Ca2+ (9.57±2.58 ng/mg protein (n=3) and 11.47±0.92 ng/mg protein (n=3); 
Student’s t-test, p=0.01 in the presence and p=0.0001 in the absence of Ca2+; Figure 
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3D). Thus, the anandamide content of the Ca2+-containing, and Ca2+-free, superfusates 
did not differ significantly from each other after the application of this substrate 
(Student’s t-test, p=0.5). 
We also compared the anandamide content of the superfusate to that of 90% of 
the cells together with the superfusate (the other 10% of the cells was used for protein 
measurements). The anandamide content of the cells and superfusate together under 
control conditions (incubation with vehicle) was 0.09 ng/mg protein (n=2; Protocol 
C). Following 100 µM 20:4-NAPE application for 5 minutes, the anandamide content 
of the cells and superfusate increased to 28.03 ng/mg protein (n=2; Data not shown). 
Together, these data indicate that the 20:4-NAPE application-evoked 
anandamide synthesis in cultured rat PSN is not affected by the removal of Ca2+ from 
the extracellular buffer. These data also show that about 2/3 of anandamide produced 
in PSN following 20:4-NAPE application, similarly to anandamide produced by 
increasing the [Ca2+]i in central neurons [8], is retained in the cells. 
 
20:4-NAPE application induces cobalt influx into a sub-population of cultured 
rat PSN  
Anandamide synthesised in PSN by increasing the [Ca2+]i induces TRPV1-
mediated excitation [44]. TRPV1 activation by anandamide results in cobalt 
accumulation in a sub-population of PSN [24, 34, 38, 39]. Therefore, to test whether 
endogenous anandamide synthesised following the application of 20:4-NAPE has 
similar effect to that synthesised in a Ca2+-sensitive manner, we studied cobalt 
accumulation during 20:4-NAPE application. The efficacy of this technique for 
assessing TRPV1-activity has been consistently demonstrated [24, 30, 34, 38, 39, 49, 
50]. 
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While application of the vehicle did not (2.63±0.34%, n=3; p=0.44, ANOVA 
followed by Fisher’s test), application of 20:4-NAPE significantly increased the 
proportion of labelled neurons and this effect was concentration-dependent (Figure 
4A-C). The lowest concentration of 20:4-NAPE which produced a significant increase 
in the proportion of labelled cells was 0.1 µM (6.44±1.16%, n=4 cultures; ANOVA 
followed by Fisher’s test, p=0.01; Figure 4C). The EC50 of 20:4-NAPE was 7.41±1.4 
µM. The majority of the cobalt-labelled cells were small diameter neurons (Figure 
4D). These observations suggest that the cobalt influx occurred in nociceptive 
neurons, the great majority of which express TRPV1 [6, 31].  
 
20:4-NAPE application induces inward currents in a sub-population of cultured 
rat PSN  
To confirm the excitatory effect of 20:4-NAPE application, we recorded 
whole cell currents from cultured rat PSN. In total, 22 cells were found that responded 
with inward currents to 50 µM 20:4-NAPE which is the near maximal concentration 
for this agent to induce cobalt uptake (Figure 5A). The peak amplitude of the response 
was -0.41±0.06 nA (n=22).  
All nine of the 20:4-NAPE-responsive neurons that we tested also responded 
to 500 nM capsaicin (Figure 5A and B). The average amplitude of the 20:4-NAPE-
evoked currents (-0.35±0.08 nA, n=9) was significantly smaller than that of the 
capsaicin-evoked currents (-2.36±0.55, n=9; Student’s t-test, p=0.002; Figure 5C). 
However, in addition to the double-responsive cells, 27 neurons which responded to 
capsaicin but not to 20:4-NAPE application were also found (data not shown). In the 
control experimets, no neurons produced any noticible responses to the vehicle (n=11, 
data not shown). 
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20:4-NAPE application increases the [Ca2+]i in a capsazepine- and rimonabant-
sensitive manner  
In order to study the pharmacological properties of the 20:4-NAPE 
application-evoked excitatory responses, we assessed changes in [Ca2+]i produced by 
the application of 50 µM 20:4-NAPE. Application of the vehicle for a minute did not 
produce any increase in the [Ca2+]i in any of the 384 KCl-responding neurons, 
whereas 234 of these 384 responded to 1 µM capsaicin application (data not shown). 
Application of 20:4-NAPE however, increased [Ca2+]i in 189 of 546 KCl-responding 
neurons (34.6%; Figure 6A and B). All the neurons that responded to 20:4-NAPE 
application, were sensitive to capsaicin (Figure 6A and B). In addition to the double-
responsive neurons, 273 of the 546 neurons (50%) responded only to capsaicin 
(Figure 6A and B). Hence, the total number of capsaicin-responsive neurons was 462 
of 546 (84.6%; Figure 6B), which was significantly higher than the proportion of 
capsaicin-sensitive neurons measured when only the vechicle (p<0.0001; Fischer’s 
exact test) or the buffer (224 of 343 cells) was applied before capsaicin application. 
The 20:4-NAPE application-evoked changes in [Ca2+]i activated more slowly than 
those evoked by capsaicin (Figure 6A). Furthermore, the amplitude of the 20:4-NAPE 
application-evoked responses were significantly smaller than those evoked by 
capsaicin when normalised to the KCl-evoked responses (20:4-
NAPE/KCl=0.15±0.01, n=189; capsaicin/KCl=0.78±0.02, n=462; Student’s t-test, 
p<0.0001; Figure 6A). Interestingly, the great majority of neurons, which generated 
responses to 20:4-NAPE application, exhibited sustained/very slowly-inactivating 
Ca2+-transients to capsaicin application. On the other hand, the great majority of 
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capsaicin-responsive neurons, which did not respond to 20:4-NAPE application, 
exhibited fast inactivation of responses during capsaicin application (Figure 6A).     
In the presence of capsazepine (5 µM) 403 KCl-responding neurons exhibited 
a stable baseline before 20:4-NAPE application. Of these 26 responded to 20:4-NAPE 
and capsaicin (6.45%; Figure 6B). In addition to these neurons, 16 cells responded 
only to 20:4-NAPE application, and 21 cells responded only to capsaicin. Thus, the 
overall proportions of both the 20:4-NAPE- (42 of 403, 10.4%) and capsaicin-
responding neurons (47 of 403, 11.7%) in the presence of capsazepine were 
significantly smaller than that measured in the absence of capsazepine (Fisher’s exact 
test, p<0.0001 for both 20:4-NAPE and capsaicin; Figure 6B). 
In the presence of rimonabant, 20:4-NAPE application increased [Ca2+]i in 105 
of 498 KCl-responding neurons with a stable base line before 20:4-NAPE application 
(21.08%, Figure 6B). This proportion was significantly smaller from that measured in 
the control (Fisher’s exact test; p<0.0001). Rimonabant however, had no significant 
effect on the overall number of capsaicin-responding neurons (421 of 498 cells, 
84.54%, p=1, Fisher’s exact test, Figure 6B). Rimonabant significantly reduced the 
amplitude of both the 20:4-NAPE application-evoked (to 20:4-
NAPE/KCl=0.12±0.009, Student’s t-test, p=0.02), and the amplitude of the capsaicin-
induced responses (to capsaicin/KCl=0.61±0.018, Student’s t-test, p<0.0001). These 
data suggest that the 20:4-NAPE application-evoked excitatory effect is mediated by 
TRPV1, and that 20:4-NAPE application, when assessed average responses, does not 
result in a CB1 receptor mediated inhibitory effect.  
 
The 20:4-NAPE application-evoked increase in [Ca2+]i in mouse PSN is mediated 
by TRPV1  
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In order to confirm the role of TRPV1 in 20:4-NAPE application-evoked 
responses, we also studied the effect of this agent on PSN isolated from WT and 
TRPV1-/- (KO) mice. Ten of 68 KCl-responsive neurons (14.71%) from WT mice 
were regarded as responsive to 20:4-NAPE (50 µM) application (Figure 7A). As in 
experiments using rat PSN cultures, all the 20:4-NAPE-responsive neurons were 
responsive to capsaicin (1 µM; Figure 7A) and the 20:4-NAPE application-evoked 
responses activated more slowly than the capsaicin-evoked responses (Figure 7A). As 
with cultures prepared from rat DRG, cultures prepared from WT mouse DRG also 
had neurons, which responded only to capsaicin (32 of 68 (48.53%); Figure 7A).  
In contrast, none of the KCl-responsive neurons (n=59) responded to 20:4-
NAPE application in cultures prepared from DRG of KO mice (Figure 7B). As 
expected, none of the neurons in the cultures prepared from DRG of KO mice 
responded to capsaicin (Figure 7B). However, 22 of the 59 KCl-responding cells 
responded to mustard oil showing that the cells were healthy and responsive to agents 
for which they expressed receptors (Figure 7B). Therefore, our findings on neurons of 
TRPV1-/- mice confirm that the 20:4-NAPE application-evoked excitatory effects are 
mediated through TRPV1.  
 
Sub-populations of cultured rat primary sensory neurons co-express TRPV1 and 
enzymes implicated in Ca2+-insensitive anandamide syntheses  
The concentration of anandamide found in the superfusate (~10 nM) is 
significantly lower than the concentration of exogenous anandamide needed to induce 
TRPV1-mediated excitatory effects [1, 12, 14, 38, 51]. Therefore, we hypothesised 
that the excitatory effect of anandamide of PSN origin is mediated through autocrine 
signalling. To find out whether there is an anatomical basis for such autocrine 
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signalling, we used combined immunostaining for studying the co-expression of 
TRPV1 with the Ca2+-insensitive anandamide-synthesising enzymes. Analysis of this 
double immunofluorescent staining showed that a significant proportion of cultured 
rat PSN exhibit co-expression for TRPV1 and the putative Ca2+-insensitive 
anandmaide-synthesising enzymes (Figure 8, Table 3). 
 
DISCUSSION 
We have shown in the present study that four of the five enzymes (ABHd4, 
GDE1, Inpp5 and PTPn22) which have been implicated previously in Ca2+-insensitive 
anandamide synthesis from 20:4-NAPE [22, 23, 32, 36, 41, 43], are found at 
transcript level (please see also Supplementary Figure 2) in cultures prepared from rat 
DRG, and at protein level in cultured rat (and mouse, see Supplementary Figure 3) 
PSN. The GDE1 protein is also expressed by non-neuronal cells as well as by PSN. 
The anti-sPLA2G1b antibody, which we used in this study, does not produce any 
staining in rat PSN cultures, although it labels cells in acini in the pancreas. RT-PCR 
shows weak expression of sPLA2G1b mRNA in PSN cultures. Hence, one cannot 
exclude the possibility that this enzyme may be expressed under the detection 
threshold of the immunostaining technique in some neurons or non-neuronal cells.   
20:4-NAPE application to PSN cultures increases the anandamide 
concentration in the cells and the superfusate. The finding that application of 20:4-
NAPE to cell-free superfusate does not increase the anandamide content of the buffer, 
together with the finding that the anandamide content of the cells and superfusate is 
greater than that of the superfusate alone indicates that 20:4-NAPE passes the cells 
membrane and anandamide is synthesised intracellularly. Indeed, all NAPE-
converting enzymes are intracellular and transiently associated with membranes to act 
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on NAPEs embedded in those [4, 22, 23, 32, 36, 41, 43]. Therefore, the conversion of 
20:4-NAPE to anandamide in an enzymatic way, as we have shown here, can be only 
through the rapid incorporation of this phospholipid into the membranes and its 
hydrolysis by some of the enzymes we investigated here. The rate of anandamide 
production induced by 100 µM 20:4-NAPE application (~38 pmol/5 minutes/mg 
protein) is well within the range of 20:4-NAPE hydrolysis (up to ~40 
pmol/minute/mg protein) measured in brain homogenates [20, 36, 37]. The 
distribution of enzymes across PSN and non-neuronal cells indicates that, while non-
neuronal cells may produce some anandamide, the greatest amount of this 
endocannabinoid/endovanilloid is likely to be synthesised in PSN.  
Calcium regulates the synthesis of anandamide mostly through the NAPE-
synthesizing enzyme known as Ca2+-dependent N-acyltransferase, which catalyses the 
formation of 20:4-NAPE [4, 8]. However, when this rate-limiting step in anandamide 
and NAEA biosynthesis is bypassed, as in our case, the only way for anandamide to 
be produced in a Ca2+-sensitive-manner is via NAPE-PLD action on 20:4-NAPE [4, 
22, 23, 32, 36, 41-43] (Figure 1). Indeed, in the absence of Ca2+, NAPE-PLD activity 
is negligible even in the presence of the substarte [42, 47], whereas increasing the 
[Ca2+]i alone results in anandamide production [8, 44]. Although, application of 20:4-
NAPE induces some increase in the [Ca2+]i, the finding that removal of Ca2+ from the 
extracellular buffer does not change the anandamide concentration in the superfusate 
suggests that Ca2+ influx during 20:4-NAPE application is not sufficiently high to 
induce NAPE-PLD activity. Hence, following 20:4-NAPE application, at least the 
great majority of anandamide is synthesised by PSN by Ca2+-insensitive pathways. 
Consequently, some of the Ca2+-insensitive anandamide-synthesizing enzymes 
present in the cultures prepared from rat DRG form functional pathways, which may 
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also include the Ca2+-independent NAPE biosynthesising enzyme previously 
identified by Jin and colleagues [17]. However, the exact identity of the pathway(s) is 
not known and attempts to dissect them would produce ambiguous results at present 
because of the unavailability of selective and specific blockers of the enzymes. 
Application of 20:4-NAPE results in cobalt-influx in a sub-population of small 
diameter cultured PSN, the majority of which express TRPV1 [6, 28, 31]. While the 
lowest concentration of 20:4-NAPE which induces a significant increase in the 
number of cobalt-labelled neurons is 0.1 µM, the lowest concentration of 20:4-NAPE 
which results in a significant increase in the anandamide content of the superfusate is 
10 µM. We have shown here however, that PSN, similarly to central neurons [8], 
retain the majority of anandamide. Hence, the concentration of anandamide at the 
intracellular anandamide-binding site of TRPV1 [18], is probably considerably higher 
than that in the superfusate. This difference renders any direct comparision between 
minimally effective concentrations of 20:4-NAPE at increasing the anandamide 
concentration in the superfusate and at evoking Co2+ uptake very difficult.  
In addition to inducing cobalt accumulation, application of 20:4-NAPE also 
increases the [Ca2+]i, and induces whole-cell currents. All the cells which respond to 
20:4-NAPE application with increased [Ca2+]i, or inward currents, in control 
conditions, also respond to the archetypical TRPV1 agonist, capsaicin. Taken 
together, these data suggest that the 20:4-NAPE application-evoked excitatory effect 
is mediated through TRPV1 in PSN. Indeed, the TRPV1 antagonist capsazepine, 
which we applied at a concentration known to have little effect on other molecules 
than TRPV1 [11], significantly reduces the proportion of neurons responding to 20:4-
NAPE application. However, the inhibitory effect of capsazepine might be different in 
species other than rat [46]. Nevertheless, the finding that cultured PSN prepared from 
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TRPV1-/- mouse DRG do not, whereas a sub-population of cultured PSN prepared 
from WT mouse DRG does, respond to 20:4-NAPE application provides evidence 
that, in PSN, the 20:4-NAPE application-evoked excitatory effect is indeed mediated 
through TRPV1.  
Several findings indicate that the 20:4-NAPE application-induced excitatory 
effects are exerted indirectly, through anandamide production. First, both the 
anandamide production, and the 20:4-NAPE application-induced cobalt accumulation, 
depend on the concentration of the substrate. Second, if 20:4-NAPE activated TRPV1 
directly all capsaicin-sensitive neurons would be expected to respond. However, we 
found that only ~40% of capsaicin-responsive neurons exhibit responses to 20:4-
NAPE application. Third, if 20:4-NAPE activated TRPV1 directly, a similar pattern 
of temperature-dependent change in the responsiveness of neurons to 20:4-NAPE and 
capsaicin is expected to occur. However, while application of 20:4-NAPE, which 
induces responses in about a third of the neurons at 37 ˚C, fails to produce responses 
in any neurons at room temperature (Supplementary Figure 4A and B). At the same 
time, the proportion of capsaicin-responsive neurons is the same at 37 ˚C and room 
temperature (Supplementary Figure 4B). Fourth, the lack of responsiveness to 20:4-
NAPE at room temperature co-occurs with a ten-fold reduction in the anandamide 
content of the superfusate following the application of 20:4-NAPE to the cells. Fifth, 
direct TRPV1 activators, such as capsaicin and anandmaide [18], activate TRPV1 
with fast kinetics. However, the kinetics of 20:4-NAPE-induced responses are 
significantly slower than those of the capsaicin-evoked responses. Sixth, the 
amplitude of whole-cell currents produced by 20:4-NAPE application, which results 
in about 30 nM anandamide when the concentration is measured in the cells and 
superfusate together, is compatible with the amplitude of whole-cell currents evoked 
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by 100 nM anandamide included into the recording electrode [12]. These findings 
together provide evidence that the 20:4-NAPE-evoked effects depend on enzyme 
activity and at least the majority, if not all, of the 20:4-NAPE application-induced 
TRPV1-mediated excitation is produced indirectly, via the conversion of 20:4-NAPE 
to anandamide. The involvement of 20:4-NAPE-derived metabolites other than 
anandamide is highly unlikely because thin layer chromatography shows the presence 
of no other lipids than anandamide and 20:4-NAPE in the superfusate (Supplementary 
Figure 5).  
The limited responsiveness of capsaicin-sensitive neurons to 20:4-NAPE may 
appear in contrast with the co-expression pattern of TRPV1 and the four enzymes we 
examined in this study. However, each of these four enzymes constitutes only a 
member of specific enzymatic pathways (Figure 1), none of which is selective for the 
synthesis of anandamide [22, 23, 32, 36, 41, 43]. Due to the unknown molecular 
identity of some enzymes, at present, it is impossible to establish the proportion of 
neurons which express (or co-express) a complete anandamide-synthesising 
pathway(s). Nevertheless, our findings suggest that less than half of TRPV1-
expressing neurons may express pathways, which are able to produce anandamide in a 
Ca2+-insensitive manner. These findings, together with the concentration of 
anandamide in the superfusate, following 20:4-NAPE application, being well below 
the minimum concentration of exogenous anandamide needed for TRPV1 activation 
[1,12,14,38,51] also suggest that anandamide synthesised in a Ca2+-insensitive 
manner, similarly to anandamide produced through a Ca2+-sensitive pathway [44], 
activates TRPV1 through autocrine signalling. Notably, the overall proportion of 
capsaicin-responsive cells is increased from ~60% to above 80% when 20:4-NAPE is 
applied before capsaicin. Further, more dual-responsive than capsaicin-only-
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responsive neurons exhibit sustained/slowly-inactating capsaicin-induced increase in 
the [Ca2+]i. Hence, the autocrine signalling by anandamide synthesised in a Ca2+-
insensitive manner by PSN seems to have some sensitising effect on TRPV1-
mediated responses, which results in exhibiting such responses above the detection 
threshold in neurons which do not produce detectable responses to capsaicin in 
control conditions.     
While exogenous anandamide induces a CB1 receptor-mediated inhibition on 
TRPV1-mediated responses in PSN [2, 14, 24, 27, 33], the selective and specific CB1 
receptor antagonist, rimonabant, reduces the proportion of neurons responding to, and 
the amplitude of responses induced by, 20:4-NAPE application. These data may 
suggest that exogenous anandamide, and anandamide produced from 20:4-NAPE via 
Ca2+-insensitive pathways may exert their actions through not completely overlapping 
mechanisms (i.e. while exogenous anandamide induces a CB1 receptor-mediated 
inhibitory effect, endogenous anandamide does not induce such effect). However, the 
effect of exogenous anandamide on TRPV1 activity depends on its concentration and 
the availability of the CB1 receptor. Hence, exogenous anandamide above 1 µM 
induces larger responses in TRPV1-CB1 receptor co-expressing human embryonic 
kidney 293 cells than in such cells when they express TRPV1 alone  [16]. 
Consistently, the exogenous anandamide-evoked excitatory effect is reduced by 
rimonabant in cultured rat PSN [35]. Further, like the effect of anandamide on 
TRPV1, the effect of capsaicin is also reduced when the CB1 receptor is not available 
either due to blocking CB1 receptor activity with rimonabant [35] or to the deletion of 
the CB1 receptor [13]. In agreement with findings in CB1-/- mice [13], we found here 
that rimonabant reduces the amplitude of capsaicin-evoked responses, but not the 
proportion of neurons responding to capsaicin. Therefore, the inhibitory effect of 
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rimonabant on the proportion of neuron responding to 20:4-NAPE by increased 
[Ca2+]i is consistent with the proposed constitutive sensitising action of the CB1 
receptor on TRPV1, which may occur under certain conditions [13, 16]. Hence the 
effects of exogenous anandamide above 1 µM and the effects of endogenous 
anandamide synthesised from 50 µM 20:4-NAPE in a Ca2+-insensitive manner, at 
least as far as activating TRPV1 and not producing CB1 receptor-mediated inhibitory 
effects are concerned, are similar in PSN. Together these findings indicate that 
anandamide that is synthesised in a Ca2+-insensitive manner from 50 µM 20:4-NAPE 
has an excitatory rather than an inhibitory effect in PSN. 
In conclusion, results of the present study show that: (a) a sub-population of 
PSN has at least one enzymatic pathway which synthesises anandamide from 20:4-
NAPE in a Ca2+-insensitive manner; (b) the synthesis of anandamide from exogenous 
20:4-NAPE primarily, if not exclusively, occurs via Ca2+-insensitive pathways; and 
(c) anandamide of PSN origin synthesised from 20:4-NAPE in a Ca2+-insensitive 
manner produces an autocrine TRPV1-mediated excitation, which may complement 
the previously reported excitatory effects on TRPV1 of anandamide synthesised in a 
Ca2+-sensitive manner in PSN (13). The effect of anandamide of PSN origin together 
with the effects of exogenous anandamide on PSN [1, 12, 14, 24, 33] emphasises the 
high degree of flexibility of action of this important lipid mediator, and its multi-
faceted role in controlling nociceptive processing [40]. Therefore, a better 
understanding of the expression and function of the anandamide-synthesising 
enzymes in PSN may allow us to control the activity of those cells, and hence develop 
more effective treatments of somato- and viscerosensory disturbances outside the 
central nervous system. 
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TABLES 
 
Table 1 
Sequences, annealing temperature and expected product size of primers used for RT-
PCR.  
 
Primer Sequence 
Temperature 
(ºC) 
Expected 
product 
size (bp) 
GDE1 F: TGCAGAAGGATTTTGTCTCC R: TTGGGGTAAAACTGTGGCTA 57 298 
ABHd4 F: CAAAGCCATGATGGAGTCCT R: GATCTCCTCCACCACAGCAT 57 244 
PTPn22 F: CATTGAAGACCCCAGGAAAA R: CAAGTTGATGGTGGGTTCCT 61 202 
sPLA2G1b F:ACTGCTACAATCAGGCCAAG R: GTGCGGTGCAGAAATAAGAC 57 292 
Inpp5 F: TACACACCTCTCACCCACCCA R: GCTGGTGAGGTTCTTCAAGC 57 160 
GAPDH F: ACCCATCACCATCTTCCA R: CATCACGCCACAGCTTTCC 57 380 
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Table 2 
List of primary and secondary antibodies used for immunostaining.  
 
Primary 
Antibodies 
(supplier) 
 
Dilution of 
primary 
antibodies 
 
Secondary antibodies 
and their dilutions 
 
GDE1 
(Santa Cruz) 
1:500 
 
AF-568 donkey anti-
rabbit IgG (1:1000) 
ABHd4 
(Santa Cruz) 
1:200 
 
AF-568 donkey anti-goat 
IgG (1:3000) 
Inpp5 
(Santa Cruz) 
1:150 
 
AF-568 donkey anti-
mouse IgG (1:1000) 
PTPn22 
(ProteinTech 
Group) 
1:500 
 
AF-568 donkey anti-
rabbit IgG (1:1000) 
sPLA2G1b 
 (Millipore) 
1:150 AF-568 donkey anti-
mouse IgG (1:1000) 
NeuN 
(Millipore) 
1:1000  AF-488 donkey anti-
mouse IgG (1:1000) 
 
TRPV1 
(different 
suppliers*) 
1:2000 
 
donkey anti-goat IgG 
(1:10000) 
*Either guinea pig anti-TRPV1 antibody (Neuromics, Edina, MN, USA) or rabbit 
anti-TRPV1antibody was used. The latter one was a kind gift from Dr. Antonio 
Avelino (Institute of Histology and Embryology, Faculty of Medicine, University of 
Porto, Porto, Portugal) and tested intensively including on dorsal root ganglia of 
TRPV1-/- mice. 
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Table 3. 
Relative number of cultured rat primary sensory neurons exhibiting 
immunopositivity for various enzymes, which are implicated in Ca2+-insensitive 
anandamide synthesis, and for TRPV1. 
 
 ABHd4 GDE1 Inpp5 PTPn22 sPLA2G1b 
Relative number 
of cells 
exhibiting 
immunopositivity 
29.8±1.9 
n=3 
40.27±9.94 
n=3 
44.1±1.9 
n=3 
48.53±10.04 
n=3 n. d. 
Relative number 
of TRPV1-
expressing cells 
50.63±3.84 
n=3 
46.6±3.46 
n=3 
56.2±4.77 
n=3 
42.4±2.37 
n=3 n. q. 
Relative number 
of TRPV1-
expressing 
neurons which 
also exhibit 
enzyme-
immunopositivity 
23.11±8.55 
n=3 
25.9±2.68 
n=3 
64.93±10.9 
n=3 
17.93±7.58 
n=3 n. d. 
Relative number 
of enzyme-
expressing 
neurons which 
also express 
TRPV1 
13.25±4.5 
n=3 
21.8±4.21 
n=3 
51.27±8.33 
n=3 
16.4±5.49 
n=3 
n. d 
 
 
n refers to the number of cultures  
n.q. = not quantified 
n.d. = not detected 
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Figure Legends 
 
Figure 1. 
Putative anandamide-synthesising enzymatic pathways.  
A schematic representation of the putative anandamide-synthesising enzymatic 
pathways. The molecular identity of six enzymes has been established so far (bold). 
While NAPE-PLD synthesises anandamide in a Ca2+-sensitive manner, other enzymes 
(underlined), the expression of which has been studied in these experiments, act in a 
Ca2+-insensitive manner. Substrates are shown in italics. Abbreviations: NAPE-PLD: 
N-acylphosphatidylethanolamine phospholipase D, GDE1: glycerophosphodiester 
phosphodiesterase 1, ABHd4: α/β-hydrolase 4, PTPn22: protein tyrosine 
phosphatase, non-receptor type 22, sPLAG1b: group 1b soluble phospholipase A2, 
Inpp5: inositol 5’ phosphatase, NAPE: N-acylphosphatidylethanolamine, PLC: 
phospholipase C. 
 
Figure 2. 
Expression of enzymes implicated in Ca2+-insensitive anandamide synthesis in 
cultured rat primary sensory neurons.  
(A) Representative gel images of reverse transcriptase polymerase chain reaction 
products. The products synthesised by specific primers to cDNA prepared by reverse 
transcribing the total RNA isolated from cultured PSN. While mRNA of all the five 
known Ca2+-insensitive enzymes are expressed in rat cultured PSN, the level of their 
expression varies; GDE1 shows the highest level of expression (please see also 
Supplementary Figure 2), while PTPn22 shows the lowest level of expression. L 
indicates ladder. The predicted size of the PCR products is shown in Table 1. 
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(B) Representative images of cultured PSN immunostained with antibodies raised 
against the putative Ca2+-insensitive anandamide-synthesising enzymes with known 
molecular identity (red) in combination with an antibody which selectively and 
specifically recognises neurons (NeuN; green). The mounting medium contains DAPI 
(blue). The anti-ABHd4, anti-GDE1, anti-Inpp5 and anti-PTPn22 antibodies produce 
staining in various sub-populations of cells. The anti-sPLA2G1b antibody does not 
produce staining. The anti-GDE1 antibody, in addition to neurons, also stains some 
non-neuronal cells (arrow). Quantitative analysis of the immunostaining is shown in 
Table 3. Bars=25 µm. 
 
Figure 3. 
20:4-NAPE application induces anandamide production in cultured rat primary 
sensory neurons. 
(A) Incubation of rat cultured PSN in the presence of 100 µM 20:4-NAPE for 5 
minutes at 37 °C results in a significant increase in the anandamide content of the 
superfusate when compared to the basal anandamide level. The measurement was 
done by ultra-high performance liquid chromatography-electrospray-tandem mass 
spectrometry following the extraction of lipids from the superfusate. Spectrograms of 
anandamide analysis are shown in Supplementary Figure 1. (n=4, * indicates 
significant difference.) 
(B) Incubation of rat cultured PSN in the presence of 100 µM 20:4-NAPE for 5 
minutes at room temperature also increases the anandamide content of the 
superfusate. However, the anandamide content following incubation of the neurons at 
room temperature is significantly smaller than following incubation of the neurons at 
37 °C (please note the difference in the scale of the y axis in (A) and (B)). 
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Spectrograms of anandamide analysis are shown in Supplementary Figure 1. (n=3, * 
indicates significant difference from the basal anandamide level measured at room 
temeprature.)  
(C) Incubation of rat cultured PSN in 30nM-100 µM 20:4-NAPE for 5 minutes at 37 
°C results in a concentration-dependent increase in the anandamide content of the 
superfusate. The lowest 20:4-NAPE concentration that induces significant increase of 
the anandamide content of the superfusate is 10µM. (n=3 for each data point, * 
indicates significant difference.)  
(D) Withdrawal of Ca2+ from the superfusate does not change either the basal 
anandamide content of the superfusate or the anandamide content of the superfusate 
following the addition of 100 µM 20:4-NAPE for 5 minutes. (n=3 for each data point, 
* indicates significant difference.) 
 
Figure 4. 
20:4-NAPE application induces cobalt uptake in a sub-population of cultured rat 
primary sensory neurons. 
(A-B) Representative images of cultured rat PSN following the incubation of cells in 
a 5 mM CoCl2-containing buffer for 5 minutes without (A) or with 20:4-NAPE (100 
µM) (B). The accumulated cobalt in the cells was precipitated by 2.5% β-
mercaptoethanol. The images are inverted hence labelled cells appear as bright cells 
which are indicated by arrows. When no 20:4-NAPE is added to the CoCl2-containing 
buffer very few cells, if any at all, accumulate cobalt (A). However, when 20:4-NAPE 
is added, a significant number of neurons accumulate Co2+ (B). 
(C) Incubation of cultured rat PSN in a CoCl2-containing buffer in the presence of 
20:4-NAPE (100 nM-100 µM) for 5 minutes results in a concentration-dependent 
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increase in the number of cobalt-labelled cells. (n=3-9 for various data points, * 
indicates significant difference.) 
(D) The overwhelming majority of neurons labelled by 20:4-NAPE application-
induced cobalt influx (black bars) are small diameter neurons. Empty bars depict non-
labelled cells. 
 
Figure 5. 
20:4-NAPE application induces inward currents in a sub-population of cultured 
rat primary sensory neurons. 
(A) A typical current trace recorded from a PSN during the application of 20:4-NAPE 
(50 µM) for 60 seconds. Bar above recording indicates 20:4-NAPE application. 
(B) The neuron shown in (A) also responds to 500 nM capsaicin. Bar above recording 
indicates capsaicin application. Note the difference in the kinetics of the 20:4-NAPE- 
and capsaicin-induced currents. 
(C) Application of capsaicin (C) (500 nM) induces a significantly greater current then 
application of 50 µM 20:4-NAPE (N). (n=9 for each data point, * indicates significant 
difference.) 
 
Figure 6. 
20:4-NAPE application induces increase in [Ca2+]i in a sub-population of 
cultured rat primary sensory neurons, which is significantly reduced by the 
inhibition of both the transient receptor potential vanilloid type 1 ion channel 
and the cannabinoid 1 receptor. 
(A) Representative recordings of changes in [Ca2+]i in cultured rat PSN superfused by 
20:4-NAPE (50 µM) (a), capsaicin (1 µM) (b) and KCl (50 mM) (c) as indicated. A 
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proportion of neurons responds to 60 second application of 50 µM 20:4-NAPE (a) by 
a slow increase in [Ca2+]i (purple trace). All the 20:4-NAPE-responding neurons also 
respond to 1 µM capsaicin (b) application (purple trace). However, not all capsaicin-
sensitive neurons (red trace) respond to 20:4-NAPE application.  
(B) The bar chart shows the proportion of neurons responding to various activators in 
the absence or presence of the transient receptor potential vanilloid type 1 ion channel 
antagonist capsazepine (5 µM) or the cannabinoid 1 receptor antagonsist rimonabant 
(200 nM). Both capsazepine and rimonabant significantly reduces the proportion of 
the 20:4-NAPE-responding cells.    
 
Figure 7. 
20:4-NAPE induces Ca2+ influx into cultured primary sensory neurons isolated 
from wild type mice but not into those which are isolated from TRPV1-/- mice. 
(A and B) Representative recordings of changes in [Ca2+]i in cultured mouse PSN 
superfused by 20:4-NAPE (50 µM) (a), capsaicin (1 µM) (b), mustard oil (50 µM) (c), 
KCl (50 mM) (d) and ionomycin (5 µM) (e) as indicated. Recordings in (A) are from 
cells dissected from a wild type mouse, whereas the recording shown in (B) is from a 
cell isolated from a TRPV1-/- mouse. A sub-population of neurons isolated from wild 
type mice (A) responds to 50 µM 20:4-NAPE application (gray trace). All these 20:4-
NAPE-responding neurons also respond to capsaicin (gray trace). However, not all 
capsaicin-responding neurons respond to 20:4-NAPE application (black trace). While 
a sub-population of neurons isolated from TRPV1-/- mice respond to mustard oil (B), 
none of the cells respond either to 20:4-NAPE or capsaicin.  
 
Figure 8 
 
 
47 
Sub-populations of cultured rat primary sensory neurons co-express TRPV1 and 
enzymes implicated in Ca2+-insensitive anandamide synthesis.   
Cultured rat PSN were incubated in antibodies raised against TRPV1 (green) and 
ABHd4, GDE1, Inpp5 or PTPn22. For quantitative data, please see Table 3. Scale 
bar=25 µm. 
  
